PMID- 25804255 OWN - NLM STAT- MEDLINE DCOM- 20160303 LR - 20150513 IS - 1532-8198 (Electronic) IS - 1092-9134 (Linking) VI - 19 IP - 3 DP - 2015 Jun TI - Angiomatoid fibrous histiocytoma: comparison of fluorescence in situ hybridization and reverse transcription polymerase chain reaction as adjunct diagnostic modalities. PG - 137-42 LID - S1092-9134(15)00046-5 [pii] LID - 10.1016/j.anndiagpath.2015.03.004 [doi] AB - Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue neoplasm of intermediate biologic potential and uncertain differentiation, most often arising in the extremities of children and young adults. Although it has characteristic histologic features of a lymphoid cuff surrounding nodules of ovoid cells with blood-filled cystic cavities, diagnosis is often difficult due to its morphologic heterogeneity and lack of specific immunoprofile. Angiomatoid fibrous histiocytoma is associated with recurrent chromosomal translocations, leading to characteristic EWSR1-CREB1, EWSR1-ATF1, and, rarely, FUS-ATF1 gene fusions; fluorescence in situ hybridization (FISH), detecting EWSR1 or FUS rearrangements, and reverse transcription-polymerase chain reaction (RT-PCR) for EWSR1-CREB1 and EWSR1-ATF1 fusion transcripts have become routine ancillary tools. We present a large comparative series of FISH and RT-PCR for AFH. Seventeen neoplasms (from 16 patients) histologically diagnosed as AFH were assessed for EWSR1 rearrangements or EWSR1-CREB1 and EWSR1-ATF1 fusion transcripts. All 17 were positive for either FISH or RT-PCR or both. Of 16, 14 (87.5%) had detectable EWSR1-CREB1 or EWSR1-ATF1 fusion transcripts by RT-PCR, whereas 13 (76.5%) of 17 had positive EWSR1 rearrangement with FISH. All 13 of 13 non-AFH control neoplasms failed to show EWSR1-CREB1 or EWSR1-ATF1 fusion transcripts, whereas EWSR1 rearrangement was present in 2 of these 13 cases (which were histopathologically myoepithelial neoplasms). This study shows that EWSR1-CREB1 or EWSR1-ATF1 fusions predominate in AFH (supporting previous reports that FUS rearrangement is rare in AFH) and that RT-PCR has a comparable detection rate to FISH for AFH. Importantly, cases of AFH can be missed if RT-PCR is not performed in conjunction with FISH, and RT-PCR has the added advantage of specificity, which is crucial, as EWSR1 rearrangements are present in a variety of neoplasms in the histologic differential diagnosis of AFH, that differ in behavior and treatment. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Thway, Khin AU - Thway K AD - Sarcoma Unit, Royal Marsden Hospital, London, UK. Electronic address: khin.thway@rmh.nhs.uk. FAU - Gonzalez, David AU - Gonzalez D AD - Molecular Diagnostics, Royal Marsden Hospital, Sutton, Surrey, UK. FAU - Wren, Dorte AU - Wren D AD - Molecular Diagnostics, Royal Marsden Hospital, Sutton, Surrey, UK. FAU - Dainton, Melissa AU - Dainton M AD - Clinical Cytogenetics, Royal Marsden Hospital, Sutton, Surrey, UK. FAU - Swansbury, John AU - Swansbury J AD - Clinical Cytogenetics, Royal Marsden Hospital, Sutton, Surrey, UK. FAU - Fisher, Cyril AU - Fisher C AD - Sarcoma Unit, Royal Marsden Hospital, London, UK. LA - eng PT - Journal Article DEP - 20150314 PL - United States TA - Ann Diagn Pathol JT - Annals of diagnostic pathology JID - 9800503 RN - 0 (EWSR1-ATF1 fusion protein, human) RN - 0 (EWSR1-CREB1 fusion protein, human) RN - 0 (FUS protein, human) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (RNA-Binding Protein FUS) RN - Histiocytoma, Angiomatoid Fibrous SB - IM MH - Adolescent MH - Adult MH - Child MH - Female MH - Histiocytoma, Malignant Fibrous/*diagnosis/genetics/pathology MH - Humans MH - In Situ Hybridization, Fluorescence/methods MH - Male MH - Middle Aged MH - Oncogene Proteins, Fusion/genetics/metabolism MH - RNA-Binding Protein FUS/genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction/methods MH - Translocation, Genetic MH - Young Adult OTO - NOTNLM OT - Angiomatoid fibrous histiocytoma OT - EWSR1-ATF1 OT - EWSR1-CREB1 OT - FUS-ATF1 OT - genetics OT - soft tissue tumor OT - translocation EDAT- 2015/03/26 06:00 MHDA- 2016/03/05 06:00 CRDT- 2015/03/26 06:00 PHST- 2015/03/06 00:00 [received] PHST- 2015/03/09 00:00 [accepted] PHST- 2015/03/26 06:00 [entrez] PHST- 2015/03/26 06:00 [pubmed] PHST- 2016/03/05 06:00 [medline] AID - S1092-9134(15)00046-5 [pii] AID - 10.1016/j.anndiagpath.2015.03.004 [doi] PST - ppublish SO - Ann Diagn Pathol. 2015 Jun;19(3):137-42. doi: 10.1016/j.anndiagpath.2015.03.004. Epub 2015 Mar 14.